Discover trends, market shifts, and competitive outlooks for the visceral pain industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Projections for the CAGR of the Visceral Pain Market Size From 2025 to 2034?
In recent times, the size of the visceral pain market has seen robust growth. The projection is predicted to increase from $13.84 billion in the year 2024 to $14.87 billion in 2025, marking a compound annual growth rate (CAGR) of 7.5%. The expansion witnessed in the past period is due to causes such as an aging populace, an uptick in chronic disease cases, progression in medical research, the growth of healthcare infrastructure, along with a rise in awareness and diagnostic rates.
The market size for visceral pain is anticipated to experience significant expansion in the coming years, with a projected valuation of $18.71 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.9%. This growth during the forecast period is linked to advancements in pain management technology, an increasing preference for non-invasive treatments, emerging and untapped markets, bespoke treatment approaches, and the incorporation of digital health solutions. Notable market trends during the projected years include a shift towards the use of multiple forms of pain management, a heightened focus on alternative therapies, the emergence of targeted therapies for specific forms of pain, the expanding influence of telemedicine in pain management, and the integration of artificial intelligence in pain evaluation.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Visceral Pain Market?
The growth of the visceral pain market is anticipated to be propelled by the escalating demand for analgesics. These are medicines that ease pain by reducing or inhibiting pain signals in the brain. By focusing on the nervous system and regulating pain signals that stem from internal organs, analgesics can effectively control visceral pain. As an example, in April 2024, the New England Journal of Medicine, a weekly medical journal based in the UK, reported that over 53,600 clinicians had started prescribing buprenorphine by December 2023. This represents a rise of 11,500 prescribers in comparison to December 2022. Hence, the growing demand for analgesics is a key factor driving the expansion of the visceral pain market.
Which Primary Segments of the Visceral Pain Market Are Driving Growth and Industry Transformations?
The visceral pain market covered in this report is segmented –
1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes
2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications
3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs
3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13950&type=smp
Which Regions Are Key Players in the Growth of the Visceral Pain Market?
North America was the largest region in the visceral pain market in 2024. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Visceral Pain Market?
Leading corporations in the visceral pain industry are advancing new product offerings, like NHE3 Inhibitor, so as to serve their clients with dependable solutions. NHE3 inhibitors comprise a category of pharmaceuticals that function by blocking the Sodium-Proton-Exchanger subtype 3 (NHE3) in the intestines. For example, in April 2022, an NHE3 Inhibitor medication, IBSRELA, was introduced by Ardelyx, an American biopharmaceutical firm. IBSRELA is an innovative therapeutic approach for adults suffering from irritable bowel syndrome coupled with constipation (IBS-C), and it operates by blocking the Sodium-Hydrogen Exchanger 3 (NHE3) in the small intestine and colon. Its effectiveness in decreasing abdominal pain has been validated through its ability to diminish visceral hypersensitivity and intestinal permeability in animal testing.
View the full report here:
https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report
What Parameters Are Used to Define the Visceral Pain Market?
Visceral pain refers to the pain that originates from the internal organs, such as the stomach, bladder, uterus, or rectum. Visceral pain can be caused by various factors, including inflammation, menstrual cramps, swelling and stretching of the organs, blockage, decreased blood flow, and tumors, especially when concentrated in the pelvis or abdomen. It is commonly associated with additional symptoms such as nausea, perspiration, or an accelerated heartbeat.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13950
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
